iron bisglycinate
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Mar 31, 2006 (NCT00727545)
Timeline
Indications
Mechanism of action
- IronSupplementation
Iron supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04477018 | N/A | Nov 11, 2017 | Bayer, Northumbria University |
| NCT04469010 | N/A | Jun 2, 2017 | Bayer, Northumbria University |
| NCT03378791 | Phase 3 | Dec 31, 2015 | Mansoura University |
| NCT00727545 | Phase 2/Phase 3 (Phase 3) | Mar 31, 2006 | Federal University of Rio de Janeiro |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 2 | 0 | 1 | 2017 |
| Northumbria University | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Federal University of Rio de Janeiro | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Mansoura University | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1